Previous Article | Next Article 
Journal of Virology, January 2000, p. 99-109, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Analysis of HCF, the Cellular Cofactor of VP16,
in Herpes Simplex Virus-Infected Cells
Sylvie
LaBoissière and
Peter
O'Hare*
Marie Curie Research Institute, Oxted, Surrey
RH8 OTL, United Kingdom
Received 13 July 1999/Accepted 17 September 1999
 |
ABSTRACT |
Herpes simplex virus (HSV) immediate-early (IE) gene expression is
initiated via the recruitment of the structural protein VP16 onto
specific sites upstream of each IE gene promoter in a multicomponent
complex (TRF.C) that also includes the cellular proteins Oct-1 and HCF.
In vitro results have shown that HCF binds directly to VP16 and
stabilizes TRF.C. Results from transfection assays have also indicated
that HCF is involved in the nuclear import of VP16. However, there have
been no reports on the role or the fate of HCF during HSV type 1 (HSV-1) infection. Here we show that the intracellular distribution of
HCF is dramatically altered during HSV-1 infection and that the protein
interacts with and colocalizes with VP16. Moreover, viral protein
synthesis and replication were significantly reduced after infection of a BHK-21-derived temperature-sensitive cell line (tsBN67)
which contains a mutant HCF unable to associate with VP16 at the
nonpermissive temperature. Intracellular distribution of HCF and of
newly synthesized VP16 in tsBN67-infected cells was similar
to that observed in Vero cells, suggesting that late in infection the
trafficking of both proteins was not dependent on their association. We
constructed a stable cell line (tsBN67r) in which the
temperature-sensitive phenotype was rescued by using an epitope-tagged
wild-type HCF. In HSV-1-infected tsBN67r cells at the
nonpermissive temperature, direct binding of HCF to VP16 was observed,
but virus protein synthesis and replication were not restored to levels
observed at the permissive temperature or in wild-type BHK cells.
Together these results indicate that the factors involved in
compartmentalization of VP16 alter during infection and that late in
infection, VP16 and HCF may have additional roles reflected in their
colocalization in replication compartments.
 |
INTRODUCTION |
One of the earliest regulatory
events after a productive infection by herpes simplex virus (HSV) is
the induction of virus immediate-early (IE) gene expression by VP16, a
structural component of the viral particle (33).
Transcriptional activation is initiated by the recruitment of VP16
(3), together with two cellular proteins, Oct-1 (31,
34, 41) and HCF (15, 50, 52), into a multicomponent
complex formed on the regulatory sites, TAATGARAT motifs, present
within each of the IE promoters (for reviews, see references
30 and 48). VP16 also plays an
essential role later in infection, in virion morphogenesis
(45). Although its precise function(s) at this stage remains
to be elucidated, VP16 has been shown to interact with at least two
virus proteins, VP22 (7) and the virion host shutoff protein
(20, 39), both of which are also assembled into the tegument.
With regard to its role in IE gene expression, previous results from
several laboratories indicate that the first step in assembly of the
multicomponent complex (called TRF.C in this work) is the formation of
a binary complex between VP16 and HCF, which subsequently associates
with Oct-1 already bound to the TAATGARAT motifs (8, 15,
46). While a precise mechanistic understanding of the role of HCF
remains to be determined, several recent reports have helped elucidate
its function in more detail. HCF is synthesized as a large,
2,035-residue precursor protein which is subsequently cleaved at
specific reiterated sites located toward the middle of the protein, to
yield a family of polypeptides (16, 50). After cleavage, the
amino- and carboxyl-terminal portions of HCF remain stably bound
together. We and others have shown recently that the region of HCF
comprising the first 380 residues binds directly to VP16 (12, 19,
38, 49). This domain of HCF contains six reiterations of about 50 residues (the kelch repeats) and is thought to form a
-propeller
structure of linked
-sheets (2, 6, 53). Residues
predicted to be present in repeats 5 and 6 of the kelch domain have
been shown to be important for VP16 binding and complex assembly
(14).
A BHK-21-derived temperature-sensitive hamster cell line
(tsBN67), which undergoes a G0/G1
cell cycle arrest at the nonpermissive temperature (29), was
rescued by HCF (9). The endogenous HCF in the cell line
contained a single amino acid substitution within the N-terminal kelch
repeats, and this mutation was shown to be the basis of the block in
cell cycle progression. However, the kelch repeat domain itself was not
sufficient for rescue of the cell cycle phenotype, which required
residues 1 to approximately 900 (49). In vitro analysis of
tsBN67 cell extracts has shown that at the nonpermissive
temperature, while the stability and processing of HCF were not
affected by the mutation, TRF.C formation and VP16 transcriptional
activity were abrogated (9). These results indicate that
VP16 may interact with HCF determinants which are involved in its cell
cycle function.
Although the importance of VP16 in stimulating IE gene expression
during HSV type 1 (HSV-1) infection has been previously established
from the analysis of viruses encoding mutant VP16 proteins (1, 32,
40), parallel studies of virus replication in cells deficient in
cellular components of the VP16 pathway have not been performed. We
therefore wished to examine the role and the fate of HCF during HSV
infection. In this report, we show that the subcellular distribution of
HCF is profoundly altered upon HSV infection and that the protein
colocalizes with a proportion of newly synthesized VP16. We also
examined the role of HCF in VP16 transcriptional activity by infecting
tsBN67 cells at the nonpermissive temperature and showed
that VP16-HCF binding was abrogated and that viral gene expression and
viral replication were significantly reduced compared to infection of
parental BHK-21 cells. In addition, we rescued the tsBN67
proliferation defect by establishing a stable cell line expressing
simian virus 5 (SV5)-tagged wild-type (wt) HCF (tsBN67r).
Infection of tsBN67r cells at the nonpermissive temperature
resulted in the binding of newly synthesized VP16 to exogenous HCF but
only partly rescued virus protein synthesis and replication.
 |
MATERIALS AND METHODS |
Virus and cells.
The BHK-21-derived temperature-sensitive
cell line tsBN67 (29) was obtained from RIKEN
Gene Bank (Tsukuba, Japan). Vero, wt BHK-21, and tsBN67
cells were maintained in Dulbecco's modified minimal essential medium
supplemented with 10% newborn calf serum. Vero and BHK-21 cells were
propagated at 37°C, whereas tsBN67 cells were propagated
at 33.5°C (permissive temperature). Previous results have
demonstrated that tsBN67 cells undergo a reversible G0/G1 block after incubation at 39.5°C
(nonpermissive temperature). The rescued cell line (tsBN67r)
was maintained at 39.5°C in the medium described below, supplemented
with G418 (0.8 mg per ml). Virus infections were carried out with HSV-1
strain 17. Vero cells were infected at a multiplicity of infection
(MOI) of 10 PFU/cell. BHK-21 and its derivatives tsBN67 and
tsBN67r were seeded 2 days prior to infection (4 × 105 cells/dish) at the assay temperature (33.5 or
39.5°C). Separate cultures of each cell types were counted
immediately prior to infection to ensure identical MOIs. Infected cells
were harvested at the indicated times postinfection (p.i.), and samples
were processed for either immunoprecipitation, Western blotting, or immunofluorescence. Total viral progeny was assayed by plaque assay on
Vero cells.
Immunoprecipitations.
Mock-infected or infected cells were
washed in cold phosphate-buffered saline, and high-salt extracts were
prepared as previously described (11, 51). VP16 was
immunoprecipitated with the anti-VP16 monoclonal antibody (MAb) LP1
(1:100) in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl,
and 1% NP-40. Immune complexes were recovered by adding protein
A-Sepharose. Beads were washed five times in the incubation buffer and
then lysed in 2× sodium dodecyl sulfate (SDS) loading buffer.
SDS-PAGE and Western blotting.
Mock-infected or infected
cells were washed in cold phosphate-buffered saline, and total lysates
were prepared by adding 250 µl of 1× SDS loading buffer. Samples
were briefly sonicated prior to electrophoresis. Equal amounts of total
proteins were fractionated by SDS-polyacrylamide gel electrophoresis
(PAGE) and transferred onto Hybond-C membranes. Primary antibodies for
immunodetection were diluted as follow: anti-IE110k (MAb 11060, 1:10,000), anti-IE175k (MAb 10176, 1:5,000), anti-HSV thymidine kinase
(1:2,000), anti-VP16 (MAb LP1 [1:4,000] or polyclonal rabbit antibody
POS1 [1:2,000]), anti-VP22 (polyclonal rabbit antibody AGV30,
1:50,000), antiactin (MAb AC-40, 1:5,000; Sigma), and anti-HCF (rabbit
polyclonal antibody, 1:10,000). Reactive proteins were visualized by
enhanced chemiluminescence (Pierce).
Immunofluorescence.
Cells grown on coverslips were mock
infected or infected with HSV at an MOI of 10 PFU/cell and were fixed
in 100% methanol for 15 min at the indicated times p.i.
Immunofluorescence reactions were carried out as described previously
(7). Primary antibodies were diluted as follows: LP1, 1:400;
anti-HCF, 1:200; anti-RNA polymerase II (Pol II) reacting against the
carboxy-terminal tail, 1:200; and anti-SV5, a mouse MAb against a short
peptide region of SV5 M protein used as an epitope tag in HCF
constructs, 1:2,000. Secondary antibodies were fluorescein-conjugated
anti-mouse immunoglobulin G (1:100) and tetramethyl rhodamine
isocyanate-conjugated anti-rabbit immunoglobulin G (1:200). Cells were
examined in a Zeiss LSM410 or Bio-Rad MRC600 confocal microscope with
an ×40 or ×63 objective lens. Images were collected by scanning each
channel separately, and control assays demonstrated no significant
cross-channel leak-over. After collection, the images were processed
and annotated with Adobe Photoshop software.
Rescue of the tsBN67 temperature-sensitive
defect.
A stable cell line expressing SV5-tagged HCF was
constructed as follow. tsBN67 cells grown for 2 days at
39.5°C were transfected with 2 µg of pSL25, a plasmid expressing
SV5-tagged full-length HCF (18), together with 2 µg of
pSV2Neo, a plasmid expressing the selectable marker for neomycin
resistance. Cells were transfected by the calcium phosphate method
modified by the inclusion of
N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid-buffered saline as previously described (10). Two days after transfection, cells were washed and incubated in the presence of
G418 (0.8 mg/ml) for 2 weeks. Individual colonies were selected and
examined for expression of exogenous HCF by Western immunoblotting and
immunofluorescence using the anti-SV5 and anti-HCF antibodies. A
suitable clone (tsBN67r) was selected and expanded for analysis.
 |
RESULTS |
The intracellular distribution of HCF is altered in HSV-infected
cells.
To determine the effect of HSV infection on HCF
localization, a time course of infection was carried out with Vero
cells. Cells were mock infected or infected at an MOI of 10, fixed at various times p.i., and stained for HCF and VP16 (Fig.
1). In mock-infected cells (Fig. 1,
Mock), HCF exhibited a diffuse nuclear pattern with the exclusion of
nucleoli, in agreement with previous results for other cell types
(16, 18). At 1 h p.i. we observed subtle but distinct
changes in HCF localization, with the appearance of speckled foci,
which became more prominent by 4 h p.i. (Fig. 1, 4 h, arrows). By
6 h p.i. significant reorganization of HCF distribution was
readily apparent (Fig. 1, 6 h, arrow, left panel), with a substantial
amount of the protein accumulating in large intranuclear domains
reminiscent of HSV replication compartments. Finally, at later times of
infection (8 to 12 h), HCF localization progressed to nuclear
honeycomb-like structures, with a minor but reproducible component in
the cytoplasm (Fig. 1, 8 to 12 h, arrows). The very early alterations
in HCF localization after infection are illustrated in a separate
experiment with higher-magnification images which show more clearly the
appearance of the protein in speckled foci between 1 and 2 h p.i.,
small bright foci by 4 h p.i., and the start of the coalescence
into larger globular domains at 6 h p.i. (Fig.
2a).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 1.
Intracellular compartmentalization of HCF and VP16 in
HSV-1-infected Vero cells. Vero cells were mock infected (Mock) or
infected with HSV-1 (strain 17) at an MOI of 10 and fixed at the
various times indicated. Double immunofluorescence was carried out with
anti-HCF and anti-VP16 (LP1) antibodies. The panel for each time point
shows the pattern of detection of HCF or VP16 in the same field of
cells. VP16 was first detected between 4 and 6 h p.i., while
concentration of HCF into speckled foci could be detected by 2 h
p.i. The later nuclear colocalization of HCF and VP16 is readily
apparent.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
HCF reorganization and colocalization with RNA Pol II.
(a) Vero cells were mock infected (Mock) or infected with HSV-1 (strain
17) at an MOI of 10 and fixed at the various times indicated. Cells
were stained with anti-HCF antibody alone and analyzed by confocal
microscopy using an ×63 objective combined with an ×2.5 digital zoom.
(b) Mock-infected or HSV-infected cells (6 h p.i.) were double labeled
for RNA Pol II and HCF. For the mock-infected cells, only RNA Pol II is
shown; for the infected cells, the panels show the same field of cells
stained for RNA Pol II or HCF, with clear colocalization of the two
proteins in globular or coalesced foci (arrows).
|
|
We have recently shown in transient transfection assays that HCF
colocalizes with VP16 (18). To determine whether such
colocalization would also be observed in the context of viral
infection, the infected cells shown in Fig. 1 were costained for VP16
(right panels). Newly synthesized VP16 was first observed between 4 and 6 h p.i. and was primarily detected in the nucleus in diffuse or
globular structures, with prominent colocalization with HCF. At later
times of infection (right panels, 8 to 12 h p.i.), most of the
intranuclear VP16 remained localized with HCF, and a distinct perinuclear accumulation could also be observed. In addition, significant amounts of diffuse cytoplasmic VP16 were observed.
Earlier studies have shown that the major DNA replication proteins of
HSV are recruited into subnuclear compartments termed replication
compartments, which progressively accumulate into large globular
domains (35). A number of cellular proteins, (e.g., RNA Pol
II, topoisomerase II, Rb, and p53) are also recruited into these sites
(36, 47). Since the pattern of relocalized HCF at later
times of infection, from 6 to 8 h onwards, was reminiscent of
replication compartments, we examined HCF location in dual-staining experiments in comparison to RNA Pol II. The results (Fig. 2b, arrowed
cells) indicate that HCF did indeed colocalize with RNA Pol II late in
infection. Together, these data demonstrate that there is a profound
reorganization of HCF during virus infection, that HCF colocalizes with
VP16, and that both proteins are present in viral replication
compartments, with additional cytoplasmic accumulation of VP16.
HCF interacts with VP16 in HSV-infected cells.
Biochemical
assays have indicated that VP16 interacts with HCF in the absence of
the other components of TRF.C, but to date there are no reports which
specifically address HCF interaction with VP16 during HSV infection.
Since we observed that HCF colocalizes with VP16, we next wished to
determine whether the two proteins directly interact with one another
during infection. Vero cells were mock infected or infected with HSV-1
at an MOI of 10 PFU/cell, and soluble extracts were prepared at 3, 6, 9, 12, and 16 h p.i. (Fig. 3).
Samples were first analyzed directly by Western blotting to evaluate
the relative amounts of proteins present in each extract (Fig. 3a).
Reaction with an antiactin antibody demonstrated that approximately
equivalent protein levels were loaded for each sample (Fig. 3a, actin).
VP16 was first detected at 6 h p.i., increasing in abundance as
infection progressed (Fig. 3a, VP16). Analysis of HCF with a polyclonal
antibody raised against the C terminus of the protein showed that its
steady-state level remained relatively constant throughout the course
of infection. Note that the slight change in ratio of the different
C-terminal species seen at 16 h p.i. was not significant and was
not reproducibly observed (see, e.g., Fig. 4). The samples were next
immunoprecipitated with a MAb against VP16, and VP16 was then
visualized with a rabbit polyclonal antibody (Fig. 3b, VP16).
Coprecipitated HCF was detected by Western blotting of the
immunoprecipitates with the anti-HCF antibody (Fig. 3b, HCF). While no
HCF was observed from the mock- or early-infected samples, as infection
progressed HCF was coprecipitated in increasing amounts, corresponding
to the amounts of precipitated VP16. While it is reasonable to expect
from previous biochemical analyses that HCF interacts with VP16
immediately after infection, the amounts of VP16 present at that time
were below our levels of detection in either total or
immunoprecipitated extracts (Fig. 3). More sensitive assays will have
to be developed to examine the HCF-VP16 interaction immediately after
infection. Nevertheless, these results demonstrate that HCF associates
with newly synthesized VP16 in HSV-1-infected cells, and it is likely
that the interaction occurs in replication compartments where the two
proteins accumulate throughout infection.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 3.
Direct interaction between HCF and VP16 in
HSV-1-infected Vero cells. Vero cells were mock infected (lane M) or
infected with HSV-1 at an MOI of 10, and soluble cell extracts were
prepared at 3, 6, 9, 12, and 16 h p.i. VP16 was immunoprecipitated
with LP1 (1:100), immune complexes were resolved in an SDS-10%
polyacrylamide gel, and proteins were transferred onto a Hybond-C
membrane. HCF and VP16 products were detected with anti-HCF and POS1
antibodies, respectively, before (a) and after (b) immunoprecipitation
(I.P.). An antiactin antibody was used to ensure that similar amounts
of proteins were present in each extract prior to
immunoprecipitation.
|
|
Reduced association of VP16 with HCF in infected tsBN67
cells.
In transfection assays, VP16 fails to activate IE
transcription in tsBN67 cells at the nonpermissive
temperature, with the defect being attributed to reduced TRF.C
formation (9, 49). We wished to examine the consequences of
the defect in HCF on VP16 function in virus-infected cells and
specifically to determine if VP16 binds to HCF in infected
tsBN67 cells at the nonpermissive temperature. Parental
BHK-21 and tsBN67 cells grown for 2 days at 33.5 and
39.5°C were infected at an MOI of 10 PFU/cell or were mock infected,
and soluble cell extracts were prepared at 16 h p.i. (Fig.
4). As before, controls with the
antiactin antibody confirmed that similar levels of proteins were
present in all cell extracts (data not shown). Levels of HCF and VP16
were first assessed prior to immunoprecipitation (Fig. 4a). HCF was
present in similar amounts in mock-infected and infected cells, both
BHK-21 and tsBN67, with little difference in relative
abundance of individual species (Fig. 4a, HCF). In infected cells, VP16
was expressed at similar levels in each of the cell types; in
particular for tsBN67, there was little reduction in
expression at the elevated temperature (Fig. 4a, VP16).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 4.
Interaction between HCF and VP16 in HSV-1-infected
BHK-21 and tsBN67 cells. BHK-21 and tsBN67 cells
grown for 2 days at 33.5 or 39.5°C were mock infected (lanes M) or
infected (lanes I) at an MOI of 10. Soluble extracts were prepared
16 h p.i., and VP16 was immunoprecipitated with LP1. Detection of
the input and immunoprecipitated proteins was as for Fig. 3.
|
|
VP16 was next immunoprecipitated with LP1, and the presence of
coprecipitated HCF was examined by Western blotting. As a control, the
membrane was also probed with a separate anti-VP16 antibody (POS1) to
confirm that similar levels of VP16 had been immunoprecipitated relative to the inputs (Fig. 3b, VP16). As expected, HCF was not recovered in any of the mock-infected cells. For infected BHK-21 cells,
HCF coprecipitation was observed at both temperatures, with if anything
slightly more HCF being detected at the elevated temperature (lanes 2 and 6). By comparison, in tsBN67 cells significantly less
HCF was observed at 39.5°C than at 33.5°C (lanes 4 and 8; see also
Fig. 7). This result demonstrates that after a high-multiplicity infection of tsBN67 cells at the restrictive temperature,
VP16 was expressed at similar levels late in infection, while there was
a clear deficiency in its ability to bind HCF.
HSV protein synthesis is severely impaired in
tsBN67-infected cells at the nonpermissive
temperature.
Previous analyses have shown that the effects of
mutations in certain viral proteins, including VP16 (1), may
be more distinct at low MOIs. Therefore, it was possible that any
consequences of reduced binding of HCF to VP16 in the tsBN67
cells would be manifest at low MOI. To address this question, BHK-21
and tsBN67 cells were grown for 2 days at 33.5 or 39.5°C
and then infected at high (10 PFU/cell) and low (0.1 PFU/cell) MOIs.
Total cell lysates prepared at various times p.i. were analyzed by
Western blotting using a variety of antibodies to different
virus-encoded proteins (Fig. 5). We first
analyzed the appearance of an IE protein, IE110k (ICP0), at the high
MOI (Fig. 5a). At both temperatures, IE110k appeared slightly earlier
in BHK-21 cells than in tsBN67-infected cells. (Note that
despite its optimal rates of synthesis at IE times, accumulation of
IE110k to maximal amounts occurs late in infection.) There was,
however, no significant difference in the expression of IE110k in
tsBN67 cells infected at the permissive compared to the
nonpermissive temperature. Similar results were obtained for the other
virus proteins (data not shown). This result suggests that at a MOI,
viral gene expression proceeds normally despite the defect in HCF.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 5.
HSV-1 protein synthesis in infected BHK-21 and
tsBN67 cells. (a) BHK-21 and tsBN67 cells grown
for 2 days at 33.5 or 39.5°C were infected with HSV-1 at an MOI of
10. Total cell lysates were prepared at 0 (lanes M), 2, 4, 6, 10, 14, 18, and 24 h p.i. Proteins were fractionated in an SDS-10%
polyacrylamide gel and transferred onto a Hybond-C membrane, and IE110k
was detected with a MAb. (b) BHK-21 and tsBN67 cells were
infected with 0.1 PFU/cell, and total cell lysates were prepared at 0 (lanes M), 4, 8, 12, 18, 24, 32, and 48 h p.i. Proteins were
fractionated in an SDS-10% polyacrylamide gel, transferred onto a
Hybond-C membrane, and reacted with antibodies directed against IE
(IE110k and IE175k), early (thymidine kinase [tk]), and late (VP16
and VP22) viral proteins, HCF, and actin, which served as a control for
the relative amounts of proteins present in each sample. Note that
threefold more lysates were used for the detection of IE175k.
|
|
By contrast, at low MOI there was a clear difference in the response to
elevated temperature between the two cell lines (Fig. 5b). At 33.5°C,
IE110k expression was slightly advanced in BHK-21 versus
tsBN67, but there was only a marginal difference between the
two lines (Fig. 5b, 33.5°C, IE110k); comparable levels of synthesis
of IE175k (ICP4) and representative members of early and late classes
of virus proteins were also observed (Fig. 5b, 33.5°C). However, at
39.5°C, while in BHK-21 cells IE110k expression appeared if anything
slightly earlier and in greater amounts than at 33.5°C, in
tsBN67 cells IE110k expression was both delayed and
significantly reduced. This divergent response to the elevated temperature resulted in a very substantial difference in the expression levels of IE110k between the two cell lines. Similar reductions in
expression of additional virus proteins were also observed (Fig. 5b,
39.5°C). As for the earlier experiments, total protein levels of HCF
and actin remained relatively constant throughout the course of
infection in both cell types (Fig. 5b, HCF and actin). Thus, from the
results for the parental BHK-21 cells, the elevated temperature does
not per se have a detrimental effect on infection or virus gene
expression, and the profound delay in viral protein expression in
tsBN67 cells infected at low MOI is consistent with the
defect in HCF abrogating TRF.C formation and IE gene expression.
In parallel with the experiments described above, we measured total
virus yields after infection at each MOI (Table
1). At an MOI of 0.1 PFU/cell, titers at
24 h p.i. show no significant difference in BHK-21 cells at
33.5°C compared to 39.5°C. In tsBN67 cells, yields were
approximately 30-fold lower at 39.5°C than at 33.5°C, and these
titers were 150-fold lower than in BHK-21 cells at 39.5°C. By 48 h p.i., the relative efficiency of replication in the tsBN67
cells had recovered somewhat, and there was only a 10-fold difference
between titers obtained from BHK-21 and tsBN67 cells
infected at 39.5°C. In addition, the titer of HSV propagated on
tsBN67 cells for 14 h at an MOI of 10 PFU/cell at the
nonpermissive temperature is 10- to 30-fold lower than titers obtained
at 33.5°C or in BHK-21 cells at both temperatures. These results
indicate that the defect in HCF results in reduced HSV replication
particularly at low MOI but that (possibly due to secondary infections
at higher MOIs) this effect is reduced at later times of infection.
Intracellular localization of HCF and VP16 in
tsBN67-infected cells.
The biochemical analysis by
coprecipitation indicated that at both MOIs, VP16 binding to HCF was
defective in tsBN67 cells at the nonpermissive temperature.
We next wished to investigate whether this defect would affect the
intracellular localization of HCF and VP16 during HSV infection. BHK-21
and tsBN67 cells were mock infected or infected at 39.5°C
with an MOI of 10 PFU/cell. Cells were fixed at 6 h p.i. and
stained with the anti-HCF antibody (Fig.
6a). In mock-infected BHK-21 cells, HCF
exhibited a diffuse nuclear localization pattern (Fig. 6a1) identical
to that observed in Vero cells (see above). In tsBN67 cells
however, while the distribution pattern of the protein was
predominantly nuclear, somewhat more cytoplasmic HCF was also detected
(Fig. 6a2). A similar pattern was observed at the permissive
temperature (data not shown). In infected cells, however, HCF was
relocalized in both BHK-21 and tsBN67 cells (Fig. 6a3 and
-4), with patterns again very similar to those observed in infected
Vero cells. Therefore, despite the defective association between HCF
and VP16 observed in coprecipitation assays, the protein was still
relocalized into replication compartments during HSV infection.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 6.
Intracellular distribution of HCF and VP16 in BHK-21 and
tsBN67 cells infected at 39.5°C. BHK-21 and
tsBN67 cells grown for 2 days at 39.5°C were mock infected
or infected with HSV-1 at an MOI of 10 and fixed 6 h later.
Indirect immunofluorescence was carried out with the anti-HCF
polyclonal antibody (a) or LP1, the anti-VP16 MAb (b).
|
|
Parallel samples were also examined for VP16 localization (Fig. 6b).
The results show that in both BHK-21 and tsBN67 cells infected at 39.5°C, VP16 was detected in the nuclear replication compartments and in the cytoplasm, and its pattern was essentially identical to that observed in Vero cells. Taken together, these results
indicate that the trafficking of HCF and VP16 late during infection
does not require a direct interaction between the two proteins.
Rescue of the tsBN67 cell defect by HCF restores VP16
interaction.
To confirm that the decrease of viral protein
synthesis and replication in tsBN67 cells at the
nonpermissive temperature was caused by the defect in HCF, we rescued
the temperature-sensitive phenotype by establishing a stable cell line
expressing full-length wild-type HCF. The tsBN67 cells were
transfected with a vector expressing SV5-tagged HCF (18),
individual colonies were selected for growth at the nonpermissive
temperature, and a suitable clone (tsBN67r) was chosen for
further experiments. Growth at 39.5°C was restored in these cells,
with a doubling time similar to that of wild-type BHK cells (results
not shown). Expression of exogenous HCF was confirmed by Western
blotting (data not shown) and by immunofluorescence analyses using the
anti-SV5 and anti-HCF antibodies (Fig.
7a). As expected, staining of
tsBN67 and tsBN67r cells with the anti-HCF
antibody revealed that HCF was present in higher amount in the nuclei
of tsBN67r cells (compare Fig. 8a2 and -4). Using the
anti-SV5 antibody to detect the N terminus of the introduced wt HCF, we
observed that while HCF was also largely nuclear, there was also some
cytoplasmic staining (Fig. 8a3). In virus-infected cells, the
SV5-tagged HCF was also relocalized into nuclear replication compartments (data not shown). Although this result was not unexpected, it confirms the relocalization that was observed in the Vero and tsBN67 cells with an independent antibody and removes the
possibility that this may have been due to the anti-HCF antibody
cross-reacting with virus components in the replication compartments.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 7.
Characterization of a stable tsBN67 cell line
expressing SV5-tagged HCF. (a) Parental tsBN67 cells (top)
and cells rescued with the SV5-tagged wt HCF (tsBN67r cells; bottom)
were grown on coverslips at 39.5°C for 2 days before fixation.
Indirect immunofluorescence was performed with either the anti-SV5 MAb
(panels 1 and 3) or the anti-HCF polyclonal antibody (panels 2 and 4).
(b) tsBN67 or tsBN67r cells grown for 2 days at
33.5°C or 39.5°C were mock infected (lanes M) or infected (lanes I)
with HSV at an MOI of 10. Soluble extracts were prepared at 16 h
p.i., and VP16 was immunoprecipitated (I.P.) with LP1 and detected by
Western blotting of the immunoprecipitates with POS1. Coprecipitated
HCF was detected with the anti-HCF antibody. The increased amount of
HCF in the rescued line is demonstrated in the top panel, showing a
Western blot of the total amount of HCF in each sample prior to the
immunoprecipitation (input). The difference in efficiency of HCF
coprecipitation at 39.5°C between the two lines can be seen by
comparing the longer (for tsBN67 cells; see also Fig. 4) and
shorter (tsBN67r cells) exposures (exp.). An antiactin antibody was
used as a control to assess the relative amounts of proteins present in
each extract.
|
|
To analyze whether the presence of the exogenous HCF was sufficient to
restore an association with VP16, tsBN67 and
tsBN67r cells were mock infected or infected at 33.5 or
39.5°C with HSV at an MOI of 10 PFU/cell. Soluble cell extracts were
prepared 16 h p.i., and VP16 was immunoprecipitated with LP1 as
before (Fig. 7b).
Prior to immunoprecipitation, samples were analyzed by Western blotting
to evaluate the relative amounts of HCF present in each cell extract
(Fig. 7, upper panels). Note that as expected, HCF was present in
higher amounts in tsBN67r cells than in tsBN67 cells (Fig. 7b, input, HCF). After VP16 immunoprecipitation, HCF was
recovered in tsBN67 infected at 33.5°C (lane 2) but in
much reduced amounts at 39.5°C (lane 6), consistent with the results in Fig. 4. By comparison, in the tsBN67r cells, HCF was
efficiently coprecipitated with VP16 at 33.5°C, and similar amounts
were coprecipitated at 39.5°C. While total HCF was more abundant in
the tsBN67r cells, the relative efficiency of HCF
coprecipitation with VP16 at 39.5°C in these cells can be readily
seen by comparing the longer (for tsBN67 cells) and shorter
(for tsBN67r cells) exposures of the blot. Controls show
that similar amounts of VP16 were immunoprecipitated (Fig. 7b, VP16).
These results demonstrate that the rescue of the temperature-sensitive
defect in a tsBN67 stable cell line expressing SV5-tagged wt
HCF restores the association of VP16 with HCF at 39.5°C.
HSV protein synthesis and replication in tsBN67r
cells.
We next wished to determine whether expression of exogenous
wt HCF would reduce the delay in virus protein synthesis and
replication observed in tsBN67 cells at the nonpermissive
temperature. In parallel, tsBN67 and tsBN67r
cells were infected (MOI of 0.1 PFU/cell) at both temperatures, and
total cell lysates were prepared at 10, 24, and 48 h p.i. Samples
were analyzed for levels of IE110k, VP22, VP16, and actin, which again
served as a control for the total protein load in each sample (Fig.
8). At 33.5°C, similar amounts of viral
proteins were synthesized in both cell lines (compare lanes 3 and 4 with lanes 7 and 8), which could be expected since HCF is functional in
the tsBN67 cells at this temperature. But it is of note that
the higher levels of HCF in the rescued tsBN67r cells did
not accelerate the progression of the HSV replicative cycle. At
39.5°C, IE110k, VP22, and VP16 were only marginally more abundant in
tsBN67r cells than in tsBN67 cells (compare lanes 11 and 12 with lanes 15 and 16). Although this effect was modest, viral
protein synthesis was detected earlier in tsBN67r cells. Nevertheless, perhaps the most salient feature of the results is that
in both cell lines, and in contrast to what was found for the parental
BHK-21 cells (Fig. 5b), lower amounts of viral proteins were detected
at 39.5°C than at 33.5°C (compare lanes 3 and 4 with 11 and 12 and
lanes 7 and 8 with 15 and 16). Even at later times of infection at
39.5°C, virus protein levels never accumulated to those observed at
33.5°C. Therefore, the delay in viral protein synthesis at 39.5°C
is only partly rescued in tsBN67r cells, and generally
levels of protein synthesis remained lower than those observed at
33.5°C or in BHK-21 cells infected 39.5°C.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 8.
HSV-1 protein synthesis in infected tsBN67
and tsBN67r cells. tsBN67 and tsBN67r
cells were grown for 2 days at 33.5 or 39.5°C exactly and then mock
infected or infected with HSV at an MOI of 0.1; protein synthesis
analyzed as for Fig. 5.
|
|
The observation of limited rescue of virus protein synthesis was
reflected in analysis of HSV replication in the tsBN67 and tsBN67r cells. The results (Table
2) show that at 24 and 48 h p.i.,
the viral titers obtained in tsBN67r cells at 39.5°C were approximately six- and threefold higher, respectively, than those obtained in tsBN67 cells. Nevertheless, the titers obtained
at 39.5°C remained lower (10- to 20-fold) than those obtained at 33.5°C in tsBN67r cells, with a ratio which was not
significantly different from that obtained for the tsBN67
cells. Taken together with the results in Fig. 5, these data indicate
that the HCF-VP16 interaction is defective in tsBN67 cells
and virus protein expression is significantly reduced at 39.5°C, but
rescue of the ts defect by wt HCF in tsBN67r
cells only partly rescues virus protein synthesis and replication.
 |
DISCUSSION |
HCF and VP16 interaction and compartmentalization in infected
cells.
While biochemical aspects of mechanism of transcriptional
activation by VP16 are understood in some detail, there are few reports
on the interactions between VP16 and its associated cellular factors in
vivo in virus-infected cells. In this study, we analyzed HCF
compartmentalization during HSV infection in wt cells and in cells
containing a mutant HCF defective in VP16 binding. We show that HCF
undergoes a subtle but distinct recruitment into small speckled foci
within 1 to 2 h p.i., and a pronounced recruitment into
concentrated and merged large globular aggregates was observed beginning at 6 to 8 h p.i. It would be reasonable to predict that the speckled foci of HCF which are seen very early after infection may
represent sites of VP16 recruitment and activity. However, using a
variety of antibodies and conditions for immunofluorescence, we have
been unable to follow the fate of input virion-associated VP16
immediately after infection.
By definition, activation of IE transcription by VP16 takes place on
input viral genomes. Results of Maul and colleagues suggest that HSV IE
transcription may take place at defined preexisting sites, overlapping
or adjacent to cellular subnuclear compartments termed nuclear domain
10 (ND10) or PML oncogenic domains (13, 25, 26). We are
currently examining whether early HCF foci exhibit any spatial
relationship with ND10 regions, an observation which would provide
mutually reinforcing evidence for a role in IE transcription.
The dramatic relocalization observed later in infection represents the
recruitment of HCF into virus replication compartments. These
structures originally defined by the progressive localization of the
major single-stranded DNA binding protein (ICP8, UL29) from
prereplicative sites into large nuclear domains (4, 22, 35)
have been shown to contain each of the essential virus DNA replication
proteins, and indeed the formation of similar compartments has been
recapitulated in transfection experiments (24, 55). In
addition, a number of cellular proteins, including RNA Pol II
(36) and tumor suppressors p53 and Rb (47, 55),
have been found to accumulate in replication compartments. Our results now indicate that HCF is also recruited into replication compartments and that within these compartments HCF is colocalized with VP16. The
precise spatial relationships between replication proteins, cleavage/packaging proteins, and mature structural proteins remain somewhat controversial 5, 21, 42, 44; for a
discussion, see reference 5). Furthermore, in
relation to the points above on the possible association of the very
early speckled foci of HCF with ND10 compartments, recent results have
indicated that only a subset of virus prereplicative sites progress to
form replication compartments, and this subset is associated with ND10
(23). It is not our point here to identify specific
subcompartments within replication compartments but to indicate that
HCF is relocalized early and that it appears to associate later with
replication compartments, where it colocalizes with VP16. Refined
analysis of HCF colocalization with ND10 and specific replication
proteins should help inform the debate on the location of active
templates early after infection and the relationship between these
sites and later replication sites. Although there is no information to
date on the relevance of the cellular proteins in replication compartments, it is clear that HCF may play an active role at stages
other than IE gene expression (see below).
Notwithstanding the various reports of subnuclear organization in
virus-infected cells, our results suggest that the mechanism responsible for the localization of HCF late in infected cells and in
particular its presence in viral replication compartments may not
require a direct association with VP16. From the immunofluorescence data, both proteins were found in replication compartments in tsBN67 cells infected at the nonpermissive temperature,
while from the biochemical data, significantly reduced amounts of HCF were found to coprecipitate with VP16. Although it is possible that the
two proteins can still interact at the nonpermissive temperature, but
do so with a weaker affinity that is more readily manifest by
coprecipitation assays than immunofluorescence assays, it is also
possible that HCF can be actively recruited through interaction(s) with
some other viral or cellular partner(s).
With regard to VP16, it was reported that at late times of infection
the protein was predominantly localized near the periphery of the
nucleus, adjacent or overlapping with nuclear subcompartments containing mature capsid proteins (44). In contrast to these results, Morrison et al. (27) observed that newly
synthesized VP16 was localized in replication compartments with ICP8,
and also in compartments with the scaffolding VP22a, suggesting that VP16 associated with sites of DNA replication and capsid maturation. Our results appear more compatible with the latter observations, but
considering the recent higher-resolution analysis and subdivision of
replication compartments by de Bruyn Kops et al. (5), more refined analysis of VP16 and HCF subnuclear localization will be required.
As pointed out previously, VP16 does not possess its own nuclear
localization signal, is largely cytoplasmic in transfection assays, and
may presumably rely on the binding to a nuclear localization signal-bearing protein for nuclear import. We have shown in
cotransfection experiments that HCF promoted nuclear import of VP16,
either directly acting as a chaperone promoting transport from the
cytoplasm or as a binding factor acting to retain VP16 in the nucleus
(18). However, our present results indicate that direct HCF
binding does not appear necessary for VP16 nuclear compartmentalization late in infection. There are several not mutually exclusive possible explanations to reconcile these results. As stated above, it is possible that HCF interaction is involved in late VP16
compartmentalization but that the interaction is not detected by
coimmunoprecipitation in the tsBN67 cells. However, in this
report we are examining the location of de novo-synthesized VP16, and
it is also possible that immediately after infection input VP16
translocates to the nucleus via an HCF-dependent pathway, whereas newly
synthesized VP16 nuclear trafficking is HCF independent. We cannot
currently test this hypothesis since we have been unable to detect
input virion-associated VP16, even using conditions similar to those described in a recent report (27), and we are attempting to devise more sensitive techniques to address this question. However, as
for capsid proteins (28, 37), it is clearly possible that VP16 late in infection is transported via an association with other
tegument proteins, and nuclear import by an association with capsid
components cannot be ruled out. Preliminary evidence indicates that
VP16 is relocalized in the nucleus in cotransfection experiments with
additional tegument proteins (G. Elliott, personal communication).
Importance of HCF in stimulating the HSV lytic cycle.
At low
MOIs in the temperature-sensitive cell line encoding a mutant HCF,
HSV-1 protein synthesis and replication were significantly reduced at
the nonpermissive temperature. Our results are consistent with previous
studies using HSV strains encoding mutant VP16 proteins which are
defective in TRF.C formation or transcriptional activation (1,
40). However, previous reports have indicated that HSV replicates
more efficiently in cycling than in growth-arrested temperature-sensitive cell lines (43, 54), and this could be
an additional contributory factor in the reduced virus expression in
the tsBN67 cells at 39.5°C. However, in the cell line
rescued for HCF function in cell cycle progression, only partial rescue of HSV replication was observed. At low MOI, virus protein synthesis was only marginally higher in the rescued cells, and the ratio of virus
yield at 39.5°C to that at 33.5°C was not substantially different
from the parental temperature-sensitive line. While these results
indicate that the reduced protein synthesis and replication were not
simply due to defective cell cycle progression, they also prompt the
question as to why the introduction of HCF did not restore virus
replication to that observed in wt BHK cells. HCF may have additional
roles in virus replication, but if anything the rescued line expressed
greater amounts of HCF, and in any case (unless this was positively
detrimental to replication) all relevant functions of HCF would have
been expected to be restored. Perhaps one explanation could be that
since the tsBN67 cells were generated by broad chemical
mutagenesis, there was disruption of additional cellular functions
which while not involved in the cell cycle block were nevertheless
important for normal levels of virus replication. These considerations
indicate that it is formally difficult to attribute the defect in virus
expression to a defect in HCF function and illustrate the complexities
in attempting to provide supporting genetic evidence for the
biochemical data implicating HCF in VP16 activity and virus
replication. However, recent biochemical results on the selective
assembly of HCF into the VP16 complex, together with studies of HCF
compartmentalization indicating that HCF is cytoplasmic in neurons but
translocates to the nucleus following stimuli which reactivate latent
HSV infections, indicate that the protein plays an important role in
virus replication (14, 17). Our results on HCF
colocalization in replication compartments, independently of direct
VP16 binding, indicate that the protein may have as yet unidentified
roles in HSV replication. Studies are now under way to relate the fate
of input VP16 to early HCF localization and to examine late HCF
compartmentalization with respect to possible subcompartments for
replication or assembly.
 |
ACKNOWLEDGMENTS |
We thank T. Minson for antibody LP1, W. Herr for the polyclonal
antibody against HCF, R. Everett for MAbs against IE110k and IE175, and
R. Randall for antibody against the SV5 epitope.
This work was funded by the Marie Curie Cancer Care.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Marie Curie
Research Institute, The Chart, Oxted, Surrey RH8 OTL, United Kingdom.
Phone: 1883-722306. Fax: 1883-714375. E-mail:
P.O'Hare{at}mcri.ac.uk.
 |
REFERENCES |
| 1.
|
Ace, C. I.,
T. A. McKee,
J. M. Ryan,
J. M. Cameron, and C. M. Preston.
1989.
Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.
J. Virol.
63:2260-2269[Abstract/Free Full Text].
|
| 2.
|
Bork, P., and R. F. Doolittle.
1994.
Drosophila kelch motif is derived from a common enzyme fold.
J. Mol. Biol.
236:1277-1282[CrossRef][Medline].
|
| 3.
|
Campbell, M. E.,
J. W. Palfreyman, and C. M. Preston.
1984.
Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.
J. Mol. Biol.
180:1-19[CrossRef][Medline].
|
| 4.
|
de Bruyn Kops, A., and D. M. Knipe.
1994.
Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures.
J. Virol.
68:3512-3526[Abstract/Free Full Text].
|
| 5.
|
de Bruyn Kops, A.,
S. L. Uprichard,
M. Chen, and D. Knipe.
1998.
Comparison of the intranuclear distributions of herpes simplex virus proteins involved in various viral functions.
Virology
252:162-178[CrossRef][Medline].
|
| 6.
|
Eichinger, L.,
L. Bomblies,
J. Vanderkerckhove,
M. Schleicher, and J. Gettemans.
1996.
A novel type of protein kinase phosphorylates actin in the actin-fragmin complex.
EMBO J.
15:5547-5556[Medline].
|
| 7.
|
Elliott, G.,
G. Mouzakitis, and P. O'Hare.
1995.
VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells.
J. Virol.
69:7932-7941[Abstract].
|
| 8.
|
Gerster, T., and R. G. Roeder.
1988.
A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins.
Proc. Natl. Acad. Sci. USA
85:6347-6351[Abstract/Free Full Text].
|
| 9.
|
Goto, H.,
S. Motomura,
A. C. Wilson,
R. N. Freiman,
Y. Nakabeppu,
K. Fukushima,
M. Fujishima,
W. Herr, and T. Nishimoto.
1997.
A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function.
Genes Dev.
11:726-737[Abstract/Free Full Text].
|
| 10.
|
Greaves, R., and P. O'Hare.
1989.
Separation of requirements for protein-DNA complex assembly from those for functional activity in the herpes simplex virus regulatory protein Vmw65.
J. Virol.
63:1641-1650[Abstract/Free Full Text].
|
| 11.
|
Greaves, R. F., and P. O'Hare.
1990.
Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences.
J. Virol.
64:2716-2724[Abstract/Free Full Text].
|
| 12.
|
Hughes, T. A.,
S. LaBoissiere, and P. O'Hare.
1999.
Analysis of functional domains of the host cell factor involved in VP16 complex formation.
J. Biol. Chem.
274:16437-16443[Abstract/Free Full Text].
|
| 13.
|
Ishov, A. M., and G. G. Maul.
1996.
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition.
J. Cell Biol.
134:815-826[Abstract/Free Full Text].
|
| 14.
|
Johnson, K. M.,
S. S. Mahajan, and A. C. Wilson.
1999.
Herpes simplex virus transactivator VP16 discriminates between HCF-1 and a novel member, HCF-2.
J. Virol.
73:3930-3940[Abstract/Free Full Text].
|
| 15.
|
Katan, M.,
A. Haigh,
C. P. Verrijzer,
P. C. van der Vliet, and P. O'Hare.
1990.
Characterization of a cellular factor which interacts functionally with Oct-1 in the assembly of a multicomponent transcription complex.
Nucleic Acids Res.
18:6871-6880[Abstract/Free Full Text].
|
| 16.
|
Kristie, T. M.,
J. L. Pomerantz,
T. C. Twomey,
S. A. Parent, and P. A. Sharp.
1995.
The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides.
J. Biol. Chem.
270:4387-4394[Abstract/Free Full Text].
|
| 17.
|
Kristie, T. M.,
J. L. Vogel, and A. E. Sears.
1999.
Nuclear localisation of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency.
Proc. Natl. Acad. Sci. USA
96:1229-1233[Abstract/Free Full Text].
|
| 18.
|
La Boissiere, S.,
T. Hughes, and P. O'Hare.
1999.
HCF-dependent nuclear import of VP16.
EMBO J.
18:480-490[CrossRef][Medline].
|
| 19.
|
LaBoissiere, S.,
S. Walker, and P. O'Hare.
1997.
Concerted action of host cell factor subregions in prommoting stable complex assembly and preventing interference by the acidic domain of VP16.
Mol. Cell. Biol.
17:7108-7118[Abstract].
|
| 20.
|
Lam, Q.,
C. A. Smibert,
K. E. Koop,
C. Lavery,
J. P. Capone,
S. P. Weinheimer, and J. R. Smiley.
1996.
Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function.
EMBO J.
15:2575-2581[Medline].
|
| 21.
|
Lamberti, C., and S. K. Weller.
1998.
The herpes simplex virus type 1 cleavage/packaging protein, UL32, is involved in efficient localization of capsids to replication compartments.
J. Virol.
72:2463-2473[Abstract/Free Full Text].
|
| 22.
|
Liptak, L. M.,
S. L. Uprichard, and D. M. Knipe.
1996.
Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures.
J. Virol.
70:1759-1767[Abstract].
|
| 23.
|
Lukonis, C. J.,
J. Burkham, and S. K. Weller.
1997.
Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments.
J. Virol.
71:4771-4781[Abstract].
|
| 24.
|
Lukonis, C. J., and S. K. Weller.
1997.
Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10.
J. Virol.
71:2390-2399[Abstract].
|
| 25.
|
Maul, G.
1998.
Nuclear domain 10, the site of DNA virus transcription and replication.
Bioessays
20:660-667[CrossRef][Medline].
|
| 26.
|
Maul, G. G.,
A. M. Ishov, and R. D. Everett.
1996.
Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1.
Virology
217:67-75[CrossRef][Medline].
|
| 27.
|
Morrison, E. E.,
A. J. Stevenson,
Y. F. Wang, and D. M. Meredith.
1998.
Differences in the intracellular localization and fate of herpes simplex virus tegument proteins early in the infection of Vero cells.
J. Gen. Virol.
79:2517-2528[Abstract].
|
| 28.
|
Nicholson, P.,
C. Addison,
A. M. Cross,
J. Kennard,
V. G. Preston, and F. J. Rixon.
1994.
Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a.
J. Gen. Virol.
75:1091-1099[Abstract/Free Full Text].
|
| 29.
|
Nishimoto, T., and C. Basilico.
1978.
Analysis of a method for selecting temperature-sensitive mutants of BHK cells.
Somatic Cell Genet.
4:323-340[CrossRef][Medline].
|
| 30.
|
O'Hare, P.
1993.
The virion transactivator of herpes simplex virus.
Semin. Virol.
4:145-155.
|
| 31.
|
O'Hare, P., and C. R. Goding.
1988.
Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation.
Cell
52:435-445[CrossRef][Medline].
|
| 32.
|
Poon, A. P., and B. Roizman.
1995.
The phenotype in vitro and in infected cells of herpes simplex virus 1 alpha trans-inducing factor (VP16) carrying temperature-sensitive mutations introduced by substitution of cysteines.
J. Virol.
69:7658-7667[Abstract].
|
| 33.
|
Post, L. E.,
S. Mackem, and B. Roizman.
1981.
Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters.
Cell
24:555-565[CrossRef][Medline].
|
| 34.
|
Preston, C. M.,
M. C. Frame, and M. E. Campbell.
1988.
A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence.
Cell
52:425-434[CrossRef][Medline].
|
| 35.
|
Quinlan, M. P.,
L. B. Chen, and D. M. Knipe.
1984.
The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication.
Cell
36:857-868[CrossRef][Medline].
|
| 36.
|
Rice, S. A.,
M. C. Long,
V. Lam, and C. A. Spencer.
1994.
RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection.
J. Virol.
68:988-1001[Abstract/Free Full Text].
|
| 37.
|
Rixon, F. J.,
C. Addison,
A. McGregor,
S. J. Macnab,
P. Nicholson,
V. G. Preston, and J. D. Tatman.
1996.
Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins.
J. Gen. Virol.
77:2251-2260[Abstract/Free Full Text].
|
| 38.
|
Simmen, K. A.,
A. Newell,
M. Robinson,
J. S. Mills,
G. Canning,
R. Handa,
K. Parkes,
N. Borkakoti, and R. Jupp.
1997.
Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements.
J. Virol.
71:3886-3894[Abstract].
|
| 39.
|
Smibert, C. A.,
B. Popova,
P. Xiao,
J. P. Capone, and J. R. Smiley.
1994.
Herpes simplex virus VP16 forms a complex with the virion host shutoff protein Vhs.
J. Virol.
68:2339-2346[Abstract/Free Full Text].
|
| 40.
|
Smiley, J. R., and J. Duncan.
1997.
Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 produces a phenotype similar to that of the
In
1814 linker insertion mutation. J. Virol. 71:6191-6193
|
| 41.
|
Stern, S.,
M. Tanaka, and W. Herr.
1989.
The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16.
Nature
341:624-630[CrossRef][Medline].
|
| 42.
|
Taus, N. S.,
B. Salmon, and J. D. Baines.
1998.
The herpes simplex virus 1 UL17 gene is required for localization of capsids and major and minor capsid proteins to intranuclear sites where viral DNA is cleaved and packaged.
Virology
252:115-125[CrossRef][Medline].
|
| 43.
|
Umene, K., and T. Nishimoto.
1996.
Replication of herpes simplex virus type 1 DNA is inhibited in a temperature-sensitive mutant of BHK-21 cells lacking RCC1 (regulator of chromosome condensation) and virus DNA remains linear.
J. Gen. Virol.
77:2261-2270[Abstract/Free Full Text].
|
| 44.
|
Ward, P. L.,
W. O. Ogle, and B. Roizman.
1996.
Assemblons: nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus 1.
J. Virol.
70:4623-4631[Abstract].
|
| 45.
|
Weinheimer, S. P.,
B. A. Boyd,
S. K. Durham,
J. L. Resnick, and D. R. O'Boyle, II.
1992.
Deletion of the VP16 open reading frame of herpes simplex virus type 1.
J. Virol.
66:258-269[Abstract/Free Full Text].
|
| 46.
|
Werstuck, G. H., and J. P. Capone.
1993.
An unusual cellular factor potentiates protein-DNA complex assembly between Oct-1 and Vmw65.
J. Biol. Chem.
268:1272-1278[Abstract/Free Full Text].
|
| 47.
|
Wilcock, D., and D. P. Lane.
1991.
Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells.
Nature
349:429-431[CrossRef][Medline].
|
| 48.
|
Wilson, A. C.,
M. A. Cleary,
J. S. Lai,
K. LaMarco,
M. G. Peterson, and W. Herr.
1993.
Combinatorial control of transcription: the herpes simplex virus VP16-induced complex.
Cold Spring Harbor Symp. Quant. Biol.
58:167-178[Medline].
|
| 49.
|
Wilson, A. C.,
R. N. Freiman,
H. Goto,
T. Nishimoto, and W. Herr.
1997.
VP16 targets an amino-terminal domain of HCF involved in cell cycle progression.
Mol. Cell. Biol.
17:6139-6146[Abstract].
|
| 50.
|
Wilson, A. C.,
K. LaMarco,
M. G. Peterson, and W. Herr.
1993.
The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein.
Cell
74:115-125[CrossRef][Medline].
|
| 51.
|
Wu, C.
1984.
Two protein-binding sites in chromatin implicated in the activation of heat-shock genes.
Nature
309:229-234[CrossRef][Medline].
|
| 52.
|
Xiao, P., and J. P. Capone.
1990.
A cellular factor binds to the herpes simplex virus type 1 transactivator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1.
Mol. Cell. Biol.
10:4974-4977[Abstract/Free Full Text].
|
| 53.
|
Xue, F., and L. Cooley.
1993.
kelch encodes a component of intercellular bridges in Drosophila egg chambers.
Cell
72:681-693[CrossRef][Medline].
|
| 54.
|
Yanagi, K.,
A. Talavera,
T. Nishimoto, and M. G. Rush.
1978.
Inhibition of herpes simplex virus type 1 replication in temperature-sensitive cell cycle mutants.
J. Virol.
25:42-50[Abstract/Free Full Text].
|
| 55.
|
Zhong, L., and G. S. Hayward.
1997.
Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
J. Virol.
71:3146-3160[Abstract].
|
Journal of Virology, January 2000, p. 99-109, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yamauchi, Y., Kiriyama, K., Kubota, N., Kimura, H., Usukura, J., Nishiyama, Y.
(2008). The UL14 Tegument Protein of Herpes Simplex Virus Type 1 Is Required for Efficient Nuclear Transport of the Alpha Transinducing Factor VP16 and Viral Capsids. J. Virol.
82: 1094-1106
[Abstract]
[Full Text]
-
Wilkinson, D. E., Weller, S. K.
(2004). Recruitment of Cellular Recombination and Repair Proteins to Sites of Herpes Simplex Virus Type 1 DNA Replication Is Dependent on the Composition of Viral Proteins within Prereplicative Sites and Correlates with the Induction of the DNA Damage Response. J. Virol.
78: 4783-4796
[Abstract]
[Full Text]
-
Luciano, R. L., Wilson, A. C.
(2002). An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP. Proc. Natl. Acad. Sci. USA
99: 13403-13408
[Abstract]
[Full Text]
-
Hutchinson, I., Whiteley, A., Browne, H., Elliott, G.
(2002). Sequential Localization of Two Herpes Simplex Virus Tegument Proteins to Punctate Nuclear Dots Adjacent to ICP0 Domains. J. Virol.
76: 10365-10373
[Abstract]
[Full Text]
-
Jenkins, H. L., Spencer, C. A.
(2001). RNA Polymerase II Holoenzyme Modifications Accompany Transcription Reprogramming in Herpes Simplex Virus Type 1-Infected Cells. J. Virol.
75: 9872-9884
[Abstract]
[Full Text]
-
Donnelly, M., Elliott, G.
(2001). Nuclear Localization and Shuttling of Herpes Simplex Virus Tegument Protein VP13/14. J. Virol.
75: 2566-2574
[Abstract]
[Full Text]
-
Mogensen, T. H., Paludan, S. R.
(2001). Molecular Pathways in Virus-Induced Cytokine Production. Microbiol. Mol. Biol. Rev.
65: 131-150
[Abstract]
[Full Text]
-
Luciano, R. L., Wilson, A. C.
(2000). N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the Host Cell Factor-1 binding motif. Proc. Natl. Acad. Sci. USA
10.1073/pnas.190062797v1
[Abstract]
[Full Text]
-
Luciano, R. L., Wilson, A. C.
(2000). N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the Host Cell Factor-1 binding motif. Proc. Natl. Acad. Sci. USA
97: 10757-10762
[Abstract]
[Full Text]